NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Match Group, Inc. (NASDAQ: MTCH) between May 2, 2023 and November 6, 2024, both dates inclusive (the “Class Period”), of the important January 24, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Match Group securities during the Class Period you may be entitled to compensation without payment of any out of pock ...

NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Symbotic Inc. (NASDAQ: SYM) between February 8, 2024 and November 26, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 3, 2025 in the securities class action first filed by the Firm. SO WHAT ...

NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS”) of Rentokil Initial plc (NYSE: RTO) between December 1, 2023 and September 10, 2024, both dates inclusive (the “Class Period”), of the important January 27, 2025 lead plaintiff deadline. SO WHAT: If you purchased Rentokil ADS during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a conting ...

NEW YORK, Dec. 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of The Toronto-Dominion Bank (NYSE: TD) between February 29, 2024 and October 9, 2024, both dates inclusive (the “Class Period”), of the important December 23, 2024 lead plaintiff deadline. SO WHAT: If you purchased TD securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Aehr Test Systems securities for the period between January 9, 2024, and March 24, 2024, due to alleged misleading statements and undisclosed delays in customer orders [3][7]. Group 1: Lawsuit Details - The class action lawsuit claims that Aehr Test Systems made false and misleading statements regarding customer order delays, which negatively impacted revenue growth and overstated the company's financial prospects [7]. - Investors who purchased Aehr securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [4][5]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [5][8]. - A lead plaintiff must be appointed by February 3, 2025, to represent the interests of the class members in the litigation [3][5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [6]. - The firm has consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [6].

NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Match Group, Inc. (NASDAQ: MTCH) between May 2, 2023 and November 6, 2024, both dates inclusive (the “Class Period”), of the important January 24, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Match Group securities during the Class Period you may be entitled to compensation without payment of any out of pock ...

NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS”) of Rentokil Initial plc (NYSE: RTO) between December 1, 2023 and September 10, 2024, both dates inclusive (the “Class Period”), of the important January 27, 2025 lead plaintiff deadline. SO WHAT: If you purchased Rentokil ADS during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a conting ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Humacyte, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The class action lawsuit pertains to securities purchased between May 10, 2024, and October 17, 2024, with a lead plaintiff deadline set for January 17, 2025 [1][2]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. Group 2: Case Allegations - The lawsuit alleges that Humacyte made false or misleading statements regarding its Durham, North Carolina facility's compliance with good manufacturing practices, which included quality assurance and microbial testing [4]. - It is claimed that the FDA's review of Humacyte's Biologics License Application would be delayed due to these compliance issues, posing a substantial risk to the approval of Acellular Tissue Engineered Vessel for vascular trauma [4]. - The lawsuit asserts that the positive statements made by Humacyte about its business and prospects were materially misleading and lacked a reasonable basis, resulting in investor damages when the truth was revealed [4]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for the number of securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3].

NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Wolfspeed, Inc. (NYSE: WOLF) between August 16, 2023 and November 6, 2024, both dates inclusive (the “Class Period”), of the important January 17, 2025 lead plaintiff deadline. SO WHAT: If you purchased Wolfspeed securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased PACS Group Inc. common stock during its IPO and subsequent securities offerings about a class action lawsuit with a lead plaintiff deadline of January 13, 2025 [1][2]. Group 1: Class Action Details - Investors who bought PACS common stock during the IPO or the class period from April 11, 2024, to November 5, 2024, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. Group 2: Allegations Against PACS - The lawsuit alleges that PACS engaged in a scheme to submit false Medicare claims, which accounted for over 100% of its operating and net income from 2020 to 2023 [5]. - Additional claims include billing for unnecessary therapies to Medicare and falsifying documentation related to licensure and staffing, leading to materially misleading statements about PACS' business and operations [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].